[1]李凤 曾健 吴镜 汪汉.心肺运动康复在老年肌少症合并冠心病治疗中的研究进展[J].心血管病学进展,2025,(7):629.[doi:10.16806/j.cnki.issn.1004-3934.2025.07.011]
　Cardiopulmonary Exercise Rehabilitation in Treatment of Elderly P atients with Sarcopenia and Coronary Heart Disease.,E-mailwujing3052@163.comE-mail7972348@qq.com[J].Advances in Cardiovascular Diseases,2025,(7):629.[doi:10.16806/j.cnki.issn.1004-3934.2025.07.011]
点击复制

心肺运动康复在老年肌少症合并冠心病治疗中的研究进展()

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年7期
页码:
629
栏目:
综述
出版日期:
2025-07-25

文章信息/Info

Title:
,E-mailwujing3052@163.comE-mail7972348@qq.com
作者:
李凤1 曾健 1 吴镜 1 汪汉2
(1.成都市第三人民医院老年医学国际医疗中心,四川 成都 610031;２.成都市第三人民医院心内科,四川 成都 610031)
Author(s):
Cardiopulmonary Exercise Rehabilitation in Treatment of Elderly P atients with Sarcopenia and Coronary Heart Disease
LI Feng1,ZENG Jian1,WU Jing1,WANG Han2 (1.Department of Geriatrics and International Medical Center ,The Third Peoples Hospital of Chengdu,Chengdu 610031,Sichuan,China; 2.Department of Cardiology,The Third Peoples Hospital of Chengdu,Chengdu 610031,Sichuan,China)
关键词:
心肺运动康复; 肌少症; 冠心病; 机制; 生存预后
Keywords:
Cardiopulmonary exercise rehabilitation; Sarcopenia; Coronary heart disease; Mechanism; Survival prognosis
DOI:
10.16806/j.cnki.issn.1004-3934.2025.07.011
摘要:
老年肌少症与冠心病的共病状态显著增加患者功能障碍及死亡风险，二者交互作用形成恶性循环。心肺运动康复通过多靶点干预，增强心肺功能及改善肌肉力量，显著降低此类患者全因死亡率和心血管事件风险，改善生存预后。心肺运动康复作为老年肌少症合并冠心病的一线干预手段，具有明确的临床获益。现综述肌少症与冠心病的关联性，心肺运动康复对老年肌少症合并冠心病的影响及治疗机制，为临床实践提供具体指导。
Abstract:
The comorbid state of sarcopenia and coronary heart disease(CHD) in the elderly significantly increases the risk of functional impairment and death,and the interaction between the two forms a vicious cycle. Cardiopulmonary exercise rehabilitation（CPER） can significantly reduce all-cause mortality and cardiovascular event risk,and improve the survival prognosis of patients by enhancing cardiopulmonary function and improving muscle strength through multi-target intervention. CPER is a first-line intervention for elderly patients with sarcopenia and CHD,with clear clinical benefits. This article reviews the interaction between sarcopenia and CHD,the impact of CPER on elderly patients with sarcopenia complicated with CHD and its therapeutic mechanisms,providing specific guidance for clinical practice

参考文献/References:

[1] Xue Q,Wu J,Ren Y,et al. Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease:a systematic review and meta-analysis[J]. BMC Geriatr,2021,21(1):493.

[2] Ding N,Ballew SH,Palta P,et al. Muscle strength and incident cardiovascular outcomes in older adults[J]. J Am Coll Cardiol,2020,75(9):1090-1092.

[3] Chen R,Xu J,Wang Y,et al. Prevalence of sarcopenia and its association with clinical outcomes in heart failure:an updated meta-analysis and systematic review[J]. Clin Cardiol,2023,46(3):260-268.

[4] 吴琳瑾,李静欣. 中国社区老年人肌少症患病率的Meta分析[J]. 现代预防医学,2019,46(22):4109-4112.

[5] Zuo X,Li X,Tang K,et al. Sarcopenia and cardiovascular diseases:a systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle,2023,14(3):1183-1198.

[6] Zhang XM,Jiao J，Zhu C，et al. Association between low handgrip strength and 90- day mortality among older Chinese inpatients:a national multicenter prospective cohort study[J]. Front Nutr,2021,8(6):628628.

[7] Sasaki KI,Kakuma T,Sasaki M,et al. The prevalence of sarcopenia and subtypes in cardiovascular diseases and a new diagnostic approach[J]. J Cardiol,2020,76(3):266-272.

[8] Zhang Y,Yang X,Bian F. TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells:crosstalk between NF-κB and PPAR-γ[J]. J Mol Cell Cardiol,2014,72:85-94.

[9] Xu T,Ding W,Ji X,et al. Oxidative stress in cell death and cardiovascular diseases[J]. Oxid Med Cell Longev,2019,2019:9030563.

[10] Nishikawa H,Fukunishi S,Asai A,et al. Pathophysiology and mechanisms of primary sarcopenia [J]. Int J Mol Med,2021,48(2):156.

[11] Damiano S,Muscariello E,la Rosa G,et al. Dual role of reactive oxygen species in muscle function:can antioxidant dietary supplements counteract age-related sarcopenia[J]. Int J Mol Sci ,2019,20(15):3815.

[12] Sakuma K,Aoi W,Yamaguchi A. Molecular mechanism of sarcopenia and cachexia:recent research advances[J]. Pflugers Arch,2017,469(5/6):573-591.

[13] Sasaki KI,Fukumoto Y. Sarcopenia as a comorbidity of cardiovascular disease[J]. J Cardiol,2022,79(5):596-604.

[14] Zeng G,Nystrom FH,Ravichandran LV,et al. Roles for insulin receptor,PI3-kinase and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells[J]. Circulation,2000,101(13):1539-1545.

[15] Hong SH,Choi KM. Sarcopenic obesity,insulin resistance,and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci,2020,21(2):494.

[16] Collins BC,Arpke RW,Larson AA. Estrogen regulates the satellite cell compartment in females[J]. Cell Rep,2019,28(2):368-381.

[17] Liu JC,Dong SS,Shen H,et al. Multi-omics research in sarcopenia:current progress and future prospects[J]. Ageing Res Rev,2022,76:101576.

[18] Wu NN,Tian H,Chen P,et al. Physical exercise and selective autophagy:benefit and risk on cardiovascular health[J]. Cells,2019,8(11):1436.

[19] Nichols S,McGregor G,Breckon J,et al. Current insights into exercise-based cardiac rehabilitation in patients with coronary heart disease and chronic heart failure[J]. Int J Sports Med,2021,42(1):19-26.

[20] Lavie CJ,Milani RV. Effects of cardiac rehabilitation and exercise training programs in patients≥75 years of age[J]. Am J Cardiol,1996,78(6):675-677.

[21] Marzolini S,Oh PI,Brooks D. Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease:a meta-analysis[J]. Eur J Prev Cardiol,2012,19(1):81-94.

[22] 马建新,熊小伟,方玮,等. 心脏康复综合管理对老年稳定性冠心病患者运动耐量及生活质量的影响[J]. 解放军预防医学杂志,2020,38(12):20-22.

[23] Leprêtre PM,Ghannem M,Bulvestre M,et al. Exercise-based cardiac rehabilitation in coronary disease:training impulse or modalities[J]. Int J Sports Med,2016,37(14):1144-1149.

[24] Milinaviciene E,Skibarkiene J,Zigmantiene D,et al. Cardiac rehabilitation for elderly patients with coronary heart disease [J]. Ann Phys Rehabil Med,2014,57S:e298.

[25] 刘遂心,陈彦颖,谢康玲,等. 有氧联合抗阻运动对冠心病患者心肺适能及运动能力的影响[J]. 中华心血管病杂志,2017,45(12):1067-1071.

[26] Josiak K,Jankowska EA,Piepoli MF,et al. Skeletal myopathy in patients with chronic heart failure:significance of anabolic andmgennic hormones[J]. J Cachexia Sarcopenia Muscle,2014,5(4):287-296.

[27] Marzuca-Nassr GN,Seron P,Román C,et al. A hybrid exercise-based cardiac rehabilitation program is an effective strategy to improve muscle strength and functional exercise capacity in adults and older people with coronary artery disease[J]. Front Physiol,2022,13:948273.

[28] Maruya K,Asakawa Y,Ishibashi H,et al. Effect of a simple and adherent home exercise program on the physical function of community dwelling adults sixty years of age and older with pre-sarcopenia or sarcopenia[J]. J Phys Ther Sci,2016,28(11):3183-3188.

[29] Fan Y,Yu M,Li J,et al. Efficacy and safety of resistance training for coronary heart disease rehabilitation:a systematic review of randomized controlled trials[J]. Front Cardiovasc Med,2021,8:754794.

[30] Campo G,Tonet E,Chiaranda G,et al. Exercise intervention improves quality of life in older adults after myocardial infarction:randomised clinical trial[J]. Heart,2020,106(21):1658-1664.

[31] Yamamoto S,Hotta K,Ota E,et al. Effects of resistance training on muscle strength,exercise capacity,and mobility in middle-aged and elderly patients with coronary artery disease:a meta-analysis[J]. J Cardiol,2016,68(2):125-134．

[32] Liang Y,Wang R,Jiang J,et al. A randomized controlled trial of resistance and balance exercise for sarcopenic patients aged 80-99 years[J]. Sci Rep,2020,10(1):18756.

[33] Linde C,Maron BJ,Udelson JE,et al. 5-Year survival benefits of CPET in geriatric CHD[J]. J Gerontol A Biol Sci Med Sci,2023,13(1):19994.

[34] Demonceau C,Reginster J,Santos J,et al. Impact of exercise interventions on mortality in older adults with sarcopenia and cardiovascular disease: a systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle,2023,11(4):620-635.

[35] Ma M,Chen W,Hua Y,et al. Aerobic exercise ameliorates cardiac hypertrophy by regulating mitochondrial quality control and endoplasmic reticulum stress through M2 AChR [J]. J Cell Physiol ,2021,236(9):6581-6596.

[36] Dun Y,Zhang W,Du Y,et al. High-intensity interval training mitigates sarcopenia and suppresses the myoblast senescence regulator EEF1E1[J]. J Cachexia Sarcopenia Muscle,2024,15(6):2574-2585.

[37] Levine B,Moulson N,Crawford SL,et al. Exercise-induced autophagy in cardiovascular and skeletal muscle health[J]. Cell Metab,2021,33(5):901-915.

[38] Zhang Y,Kamp TJ,Granzier HL,et al. SIRT1/FoxO-mediated autophagy in sarcopenia: role of exercise[J]. Aging Cell,2023,22(2):e13789.

[39] Hambrecht R,Empen K,Fuernau G,et al. Effects of exercise on microvascular function in aging and disease[J]. Hypertension,2022,79(4):1123-1135.

[40] 廖芳,张米莉,吴民俊,等. 心脏外科手术患者术前预康复的研究进展[J]. 心血管病学进展,2025,46(2):114-118.

相似文献/References:

[1]高亮 芦颜美.慢性心力衰竭并发肌少症和恶病质的诊治进展[J].心血管病学进展,2023,(7):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
　GAO Liang,LU Yanmei.Diagnosis and Treatment of Chronic Heart Failure Complicated with Sarcopenia and Cachexia[J].Advances in Cardiovascular Diseases,2023,(7):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
[2]李莹洁 周闻禄 吴镜.抗阻训练对心力衰竭合并肌少症的影响及相关机制研究进展[J].心血管病学进展,2023,(11):1005.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.011]
　LI Yingjie,ZHOU Wenlu,WU Jing.Effect and Related Mechanisms of Resistance Training on Heart Failure Complicated with Sarcopenia[J].Advances in Cardiovascular Diseases,2023,(7):1005.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.011]
[3]余思芸 吴镜.肌少症与老年高血压相关性的研究进展[J].心血管病学进展,2025,(8):690.[doi:10.16806/j.cnki.issn.1004-3934.2025.08.005]
　YU Siyun,WU Jing.Association Between Sarcopenia and Hypertension in the Elderly[J].Advances in Cardiovascular Diseases,2025,(7):690.[doi:10.16806/j.cnki.issn.1004-3934.2025.08.005]
[4]李莹洁 吴镜.老年肌少症与冠状动脉粥样硬化性心脏病相关性的研究进展[J].心血管病学进展,2025,(12):1081.[doi:10.16806/j.cnki.issn.1004-3934.2025.12.006]
　LI Yingjie,WU Jing.Relationship Between Senile Myopenia and Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2025,(7):1081.[doi:10.16806/j.cnki.issn.1004-3934.2025.12.006]

更新日期/Last Update: 2025-09-30